Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 7/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.47 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639350 | 0.96 | FTO (0.51) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL1639993 | 0.91 | FTO (0.47) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL1639333 | 0.91 | FTO (0.47) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL10520882 | 0.86 | FTO (0.53) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL1638516 | 0.83 | FTO (0.46) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL1640404 | 0.82 | CYP3A4 (0.44) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL25633972 | 0.82 | CYP3A4 (0.54) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL10518377 | 0.82 | FTO (0.59) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL1638523 | 0.80 | CYP3A4 (0.53) | FTOMAPTMEN1KMT2AHTT | |
| SCHEMBL1640135 | 0.80 | FTO (0.56) | FTOMAPTMEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110098487-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. | 2011-04-28 | — | — | US | disclosed |
| US-7807607-B2 | Color-forming compounds and use thereof in imaging members and methods | ZINK IMAGING, INC. (US) | 2010-10-05 | — | — | US | disclosed |
| WO-2010075544-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. (US) | 2010-07-01 | — | — | WO | disclosed |
| US-20090137389-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, INC. | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098487-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | HCCS, RB1, CACYBP | FTO 2797/4885MAPT 520/4885MEN1 2050/4885 |
| US-20090137389-A1 | NOVEL COLOR-FORMING COMPOUNDS AND USE THEREOF IN IMAGING MEMBERS AND METHODS | HCCS, RB1, CACYBP | FTO 2797/4885MAPT 520/4885MEN1 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.